Luye Medical Group Pte. Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Luye Medical Group Pte. Ltd. - overview

Established

2015

Location

Singapore, -, Singapore

Primary Industry

Healthcare

About

Based in Singapore, and founded in 2015, Luye Medical Group Pte. Ltd. is a regional healthcare services arm of Luye Life Sciences Group. As of May 2021, it owns 50 healthcare facilities across China, Australia, New Zealand, and Singapore, and has 10,000 staff members all working under the leadership of its CEO, Charles Wang.


Luye Medical Group Pte. Ltd. operates 2 healthcare assets, Luye Medical International Group and Luye Medical China. Luye Medical International Group comprises hospitals that offer tertiary and specialist hospitals, specialist clinics, day surgery centers, community care centers in Australia and New Zealand, as well as specialist oncology and cardiology services in key private hospitals within Singapore.


As of May 2021, Luye Medical China is a joint collaboration with Cleveland Clinic under Luye Medical China where plans of building a hospital are underway in Shanghai New Hong Qiao International Medical Center.


Primary Industry

Healthcare

Sub Industries

Hospitals, Clinics/Outpatient Services, Oncology/Cancer Treatment, Cardiology

Website

www.luyemedical.com

Total Amount Raised

Subscriber access only

Luye Medical Group Pte. Ltd. - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Luye Medical Group Pte. Ltd. - financials

Fiscal Year EndedDec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Revenue (USD)----------
% Revenue Growth (YoY)----------
EBITDA (USD)(219,851)(3,048,962)(29,823,067)(7,452,648)(4,838,565)2,845,546(2,767,034)---
Operating Income (USD)(219,851)(3,049,156)(29,827,141)(7,464,716)(4,855,288)2,831,469(2,775,047)---
Operating Margin----------
% EBITDA Margin----------
NET Income (USD)(219,851)(3,049,156)(29,827,141)(7,464,716)(4,855,288)2,831,469(2,775,047)---
% Net Margin----------

Luye Medical Group Pte. Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Spin-OffCompletedOncoCare Medical Pte. Ltd.-
Spin-OffCompletedNovena Heart Centre-
Trade SaleCompletedHealthe Care Australia Pty Ltd-

Displaying 1 - 3 of 3

Luye Medical Group Pte. Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.